June 15, 2020 / 12:51 PM / a month ago

BRIEF-Atyr Pharma Announces Dosing Of First Patient In Phase 2 Trial Of ATYR1923 In Covid-19 Patients

June 15 (Reuters) - aTyr Pharma Inc:

* ATYR PHARMA ANNOUNCES DOSING OF FIRST PATIENT IN PHASE 2 TRIAL OF ATYR1923 IN COVID-19 PATIENTS WITH SEVERE RESPIRATORY COMPLICATIONS

* ATYR PHARMA ANNOUNCES DOSING OF FIRST PATIENT IN PHASE 2 TRIAL OF ATYR1923 IN COVID-19 PATIENTS WITH SEVERE RESPIRATORY COMPLICATIONS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below